| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/12/2009 | US20090041665 Method for gene delivery to neuronal cells |
| 02/12/2009 | CA2695514A1 Ultraconserved regions encoding ncrnas |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2695433A1 Lentiviral gene transfer vectors and their medicinal applications |
| 02/11/2009 | EP2022856A2 Improvements in or relating to binding proteins for recognition of DNA |
| 02/11/2009 | EP2022853A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof |
| 02/11/2009 | EP2022851A1 Method of transferring substance into cell |
| 02/11/2009 | EP2022800A2 Compositions for the therapy and diagnosis of ovarian cancer |
| 02/11/2009 | EP2021502A1 Novel genes and markers in type 2 diabetes and obesity |
| 02/11/2009 | EP2021485A2 System for transposing hyperactive recombinant derivatives of mos-1 transposon |
| 02/11/2009 | EP2021484A1 Expression vectors comprising the hs1 promoter of the vav1 oncogene and use thereof for the preparation of pharmaceutical compositions intended for somatic gene therapy |
| 02/11/2009 | EP2021482A1 Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
| 02/11/2009 | EP2021035A2 Cell-matrix microspheres, methods for preparation and applications |
| 02/11/2009 | EP1748792B1 Compositions comprising demethylating agents as enhancers of immunotherapy for the treatment of chronic infections and neoplastic diseases and methods for treating the same |
| 02/11/2009 | EP1594968B1 Fireproof roller shutters and method for producing a fireproof roller shutter |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1409012B1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 02/11/2009 | EP1317258B1 Use of allopurinol for the treatment of hypertension |
| 02/11/2009 | EP1259258B1 Gm-negative ehv-mutants |
| 02/11/2009 | EP1210453B1 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | CN101365494A Compositions and methods for treatment of autoimmune disease |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/11/2009 | CN101363028A Complementary type high capacity adenoviral vector and vaccine and gene therapy producers constructed by the same |
| 02/11/2009 | CN101363027A Method for preparing recombination plasmid carrying short hairpin RNA and use |
| 02/11/2009 | CN101363010A Liver bud stem cell, preparation method and application thereof |
| 02/11/2009 | CN101361984A Use of Dpys 12 gene in preparing medicine for inhibiting or promoting early neurogenesis |
| 02/11/2009 | CN101361983A Lung cancer DNA plasmid vaccine and preparation method thereof |
| 02/11/2009 | CN100460874C Method for sieving crimp-relevant protain activator or antagonist |
| 02/11/2009 | CN100460018C Polybutylcyanoacrylate nano-granule with resolubity, application and use thereof |
| 02/10/2009 | US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 02/10/2009 | US7488808 Janus family kinases and identification of immune modulators |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |
| 02/10/2009 | US7488791 capable of stimulating the production of anti-HPV T CD4+ lymphocytes for vaccination against uterine of uterus cancer or as diagnostic reagent of HPV-specific T lymphocytes, in particular for assessing the immune condition of patients |
| 02/10/2009 | US7488719 heparin sulfate-decorated Perlacan (proteoglycan); administered internally or topically, or is expressed from exogenously added nucleic acids; surgery |
| 02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 02/10/2009 | US7488588 Compounds related to or derived from GFR α4 and their use |
| 02/10/2009 | US7488485 Viral proteins which stimulating immunology response |
| 02/10/2009 | US7488477 Identification and cloning of a novel neutralizing human monoclonal antibody to the Respiratory Syncytial Virus. The invention provides such antibodies, fragments of such antibodies retaining RSV-binding ability, chimeric antibodies |
| 02/10/2009 | CA2339299C Method of modulating memory effector t-cells and compositions |
| 02/10/2009 | CA2331368C Nucleic acid vaccines for prevention of flavivirus infection |
| 02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
| 02/10/2009 | CA2166318C Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 02/05/2009 | WO2009018493A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | WO2009018303A2 Methods for reverting methylation by targeting dnmt3a and dnmt3b |
| 02/05/2009 | WO2009018219A2 Methods and compositions for modulating rad51 and homologous recombination |
| 02/05/2009 | WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein |
| 02/05/2009 | WO2009016855A1 Method of preventing hair loss and method of preventing hair depigmentation |
| 02/05/2009 | WO2009016691A1 Cancer associated gene ly6k |
| 02/05/2009 | WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin |
| 02/05/2009 | WO2009015852A1 Virus-modified bacteria ghosts |
| 02/05/2009 | WO2009015491A1 Umps isoforms as novel predictive markers and therapeutic targets for chemotherapeutics |
| 02/05/2009 | WO2007144647A3 Adjuvant compositions |
| 02/05/2009 | US20090038022 IGF-1 Novel peptides |
| 02/05/2009 | US20090036661 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 02/05/2009 | US20090036395 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 02/05/2009 | US20090036393 Vesicular monoamine transporter gene therapy in Parkinson's disease |
| 02/05/2009 | US20090036391 Modulation of line-1 reverse transcriptase |
| 02/05/2009 | US20090036383 Compositions and methods for promoting lipid mobilization in humans |
| 02/05/2009 | US20090036371 Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents |
| 02/05/2009 | US20090035862 Methods and compositions for genomic modification |
| 02/05/2009 | US20090035854 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 02/05/2009 | US20090035853 Tsg101-gag interaction and use thereof |
| 02/05/2009 | US20090035752 detecting whether CpG sequences in a region from base 374 to base 592 in a DR3 gene promoter region obtained from synovial cells or synovial infiltrating lymphocytes of the human subject are methylated or not |
| 02/05/2009 | US20090035358 Phosphatidyl oligoglycerols |
| 02/05/2009 | US20090035347 Isolated stromal cells and methods of using the same |
| 02/05/2009 | US20090035331 Systems and Methods for Targeted and Controlled Delivery of Agents |
| 02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
| 02/05/2009 | US20090035310 Cancer treatment |
| 02/05/2009 | US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
| 02/05/2009 | US20090035282 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 02/05/2009 | US20090035277 Hepatitis C Virus Nucleic Acid Vaccine |
| 02/05/2009 | US20090035275 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of NAD |
| 02/05/2009 | CA2697127A1 Adeno-associated viral vectors for the expression of dysferlin |
| 02/05/2009 | CA2695184A1 Methods for reverting methylation by targeting dnmt3a and dnmt3b |
| 02/05/2009 | CA2694930A1 A micro-rna family that modulates fibrosis and uses thereof |
| 02/05/2009 | CA2694928A1 Micro-rnas that control myosin expression and myofiber identity |
| 02/05/2009 | CA2694610A1 Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method |
| 02/04/2009 | EP2019863A1 High-titer retroviral packaging cells |
| 02/04/2009 | EP1299529B1 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 02/04/2009 | EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 02/04/2009 | CN101360998A Na+, k+-atpase expression in cervical dysplasia and cancer |
| 02/04/2009 | CN101360821A Stabilizing formulations for recombinant viruses |
| 02/04/2009 | CN101358201A Recombinant human iron-regulatory hormone adenovirus, preparation method and application thereof |
| 02/04/2009 | CN101358200A RNA interference expression plasmid- cationic liposome-heparin antineoplastic complexes targeting human FAK and PLK1 gene |
| 02/04/2009 | CN101357947A Preparation and application of tumour vascular targeting agent VEGF*/RIP30fusion toxin |
| 02/04/2009 | CN101357231A Cellular membrane bionics modified nanometer gene vector combination and preparation method thereof |
| 02/04/2009 | CN101357227A Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 02/04/2009 | CN100457914C Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
| 02/04/2009 | CN100457911C Recombinant plasmid containing effective B cell activation factor gene promotor and its preparation method and uses |
| 02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 02/04/2009 | CN100457781C Antibodies against cancer |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/04/2009 | CN100457190C Promoters exhibiting endothelial cell specificity and methods of using same |
| 02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
| 02/04/2009 | CN100457094C Preparing process of biodegradable capsule loading medicine and nano magnetic particle |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |